Bioton (WAR:BIO) FFO


WAR:BIO Bioton SA WAR:BIO
67 GF Score
Price zł3.97
GF Value zł4.74
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Bioton FFO?

FFO (Funds from operations) only applies to REITs.

WAR:BIO
67GF Score
Bioton SA WAR:BIO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bioton (WAR:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Bioton stock appears to be undervalued. The current stock price of zł3.97 is trading 16.4% below its estimated GF Value™ of zł4.74. GuruFocus considers Bioton to be Modestly Undervalued.

Key valuation signals for WAR:BIO:

  • FFO:
  • GF Value™: zł4.74 vs. price of zł3.97 (16.4% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the WAR:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioton Business Description

Other Exchanges 7U5:Germany
Address Ul. Starościńska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
67GF Score

Get the complete analysis for WAR:BIO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.97
Price
zł4.74
GF Value